BioAge Labs (BIOA) Total Debt (2023 - 2026)

BioAge Labs has disclosed Total Debt across 4 years of filings, most recently posting $1.2 million for Q1 2026.

• Total Debt for Q1 2026 came in at $1.2 million, down 83.57% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 million (down 83.57% YoY), and the FY2025 annual result was $2.6 million, down 68.85% from the prior year.
• Total Debt came in at $1.2 million for Q1 2026 at BioAge Labs, down from $2.6 million in the prior quarter.
• In the past five years, Total Debt ranged from a high of $14.2 million in Q4 2023 to a low of $1.2 million in Q1 2026.
• The 4-year median for Total Debt is $6.3 million (2025), against an average of $6.7 million.
• Across the five-year window, Total Debt plunged 40.13% in 2024 and sank 83.57% in 2026, its largest moves.
• BioAge Labs' Total Debt stood at $14.2 million in 2023, then slumped by 40.13% to $8.5 million in 2024, then sank by 68.85% to $2.6 million in 2025, then plunged by 56.23% to $1.2 million in 2026.
• The last three Total Debt figures came in at $1.2 million (Q1 2026), $2.6 million (Q4 2025), and $4.1 million (Q3 2025), per Business Quant data.